Amydis Inc.
Clinical trials sponsored by Amydis Inc., explained in plain language.
-
Eye scan could spot Alzheimer's without brain scans
Diagnosis Recruiting nowThis study tests a single dose of AMDX-2011P, a dye injected into the blood, to see if it can safely detect Alzheimer's-related amyloid in the retina. 25 adults with confirmed Alzheimer's will receive the dye and undergo eye imaging. The goal is to find a simpler, less invasive w…
Phase: PHASE2 • Sponsor: Amydis Inc. • Aim: Diagnosis
Last updated May 20, 2026 11:56 UTC
-
Eye test could reveal hidden brain bleeding risk
Diagnosis Recruiting nowThis study tests a single injection of AMDX-2011P, a dye that may light up harmful protein clumps in the retina. Researchers want to see if it can help diagnose cerebral amyloid angiopathy (CAA), a condition that raises the risk of brain bleeds. About 25 adults with CAA will take…
Phase: PHASE2 • Sponsor: Amydis Inc. • Aim: Diagnosis
Last updated May 18, 2026 12:07 UTC